Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test

European Journal of Pharmacology

Volumn 575, Issue 1-3, 2007, Pages 87-93

  Budni, Josiane ^a   Gadotti, Vinícius M ^a   Kaster, Manuella P ^a   Santos, Adair R S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Agmatine; Antidepressant; Forced swimming test; K+ channels

Indexed keywords

AGMATINE; AMITRIPTYLINE; APAMIN; ARGININE; CHARYBDOTOXIN; CITALOPRAM; CLOMIPRAMINE; CROMAKALIM; DESIPRAMINE; GLIBENCLAMIDE; GLIQUIDONE; IMIPRAMINE; MAPROTILINE; MINOXIDIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NORTRIPTYLINE; PAROXETINE; POTASSIUM CHANNEL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

AGMATINE; ANIMALS; ANTIDEPRESSIVE AGENTS; APAMIN; ARGININE; CHARYBDOTOXIN; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYBURIDE; INJECTIONS, INTRAVENTRICULAR; MICE; MOTOR ACTIVITY; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING; TETRAETHYLAMMONIUM;

EID: 35348890947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.010     Document Type: Article

References (49)

1. + channels in cGMP-mediated pial artery vasodilation. Am. J. Physiol. 270 (1996) 423-426
2. Arteni N.S., Lavinsky D., Rodrigues A.L., Frison V.B., and Netto C.A. Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol. Learn. Mem. 78 (2002) 465-469
3. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., and Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
4. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-161
5. Choi J.S., Choi B.H., Ahn H.S., Kim M.J., Han T.H., and Rhie D.J. Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons. Brain Res. 1018 (2004) 201-207
6. + current by nucleotide phosphates in isolated rabbit pulmonary myocytes. Cardiovasc. Res. 3 (1995) 460-468
7. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23 (2002) 238-245
8. Demehri S., Homayoun H., Honar H., Riazi K., Vafaie K., Roushanzamir F., and Dehpour A.R. Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide. Neuropharmacology 45 (2003) 534-542
9. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochem. Biophys. Acta 1411 (1999) 334-350
10. + channels and contraction of cultured smooth muscle cells of porcine coronary artery. J. Pharmacol. Exp. Ther. 256 (1991) 371-377
11. Gadotti V.M., Tibola D., Paszcuk A.F., Rodrigues A.L.S., Calixto J.B., and Santos A.R.S. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Brain Res. 1093 (2006) 116-122
12. Gálea E., Regunathan S., Eliopoulos V., Feinstein D.L., and Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316 (1996) 247-249
13. Galeotti N., Ghelardini C., Caldari B., and Bartolini A. Effect of potassium channel modulators in mouse forced swimming test. Br. J. Pharmacol. 126 (1999) 1653-1659
14. Guo W.Y., Todd K.G., Bourin M., and Hascoet M. The additive effects of quinine on antidepressant drugs in the forced swimming test in mice. Psychopharmacology 121 (1995) 173-179
15. Guo W., Todd K., Bourin M., Hascoet M., and Kouadio F. Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol. Biochem. Behav. 54 (1996) 725-730
16. Heurteaux C., Lucas G., Guy N., El Yacoubi M., Thummler S., Peng X.D., Noble F., Blondeau N., Widmann C., Borsotto M., Gobbi G., Vaugeois J.M., Debonnel G., and Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 9 (2006) 1134-1141
17. Inan S.Y., Yalcin I., and Aksu F. Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol. Biochem. Behav. 77 (2004) 457-464
18. + channels (rSlo). Mol. Cells 12 (2001) 97-102
19. Kaczorowski G.J., and Garcia M.L. Pharmacology of voltage-gated and calcium-activated potassium channels. Curr. Opin. Chem. Biol. 3 (1999) 448-458
20. Kaster M.P., Ferreira P.K., Santos A.R.S., and Rodrigues A.L.S. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res. 165 (2005) 204-209
21. Kaster M.P., Budni J., Binfare R.W., Santos A.R.S., and Rodrigues A.L.S. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 (2007) 690-696
22. + channels by various antidepressant drugs. Neuropsychopharmacology 29 (2004) 1841-1851
23. + channels by the antidepressant paroxetine. J. Pharmacol. Sci. 102 (2006) 278-287
24. Li Y.F., Gong Z.H., Cao J.B., Wang H.L., Luoi Z., and Li J. Antidepressant-like effect of agmatine and its possible mechanism. Eur. J. Pharmacol. 469 (2003) 81-88
25. MacKinnon R. Potassium channels. FEBS Lett. 555 (2003) 62-65
26. Mathie A., Wooltorton J.R., and Watkins C.S. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen. Pharmacol. 30 (1998) 13-24
27. Moinard C., Cynober L., and de Bandt J.P. Polyamines: metabolism and implications in human diseases. Clin. Nutr. 24 (2005) 184-197
28. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268 (1995) 799-822
29. + channels by antidepressant drugs. Eur. J. Pharmacol. 452 (2002) 35-48
30. Olmos G., De Gregorio-Rocasolano N., Regalado M.P., Gasull T., Boronat M.A., Trullas R., Villarroel A., Lerma J., and Garcia-Sevilla J.A. Protection by imidazoline drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol. 127 (1999) 1317-1326
31. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
32. Raasch W., Schafer U., Chun J., and Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br. J. Pharmacol. 133 (2001) 755-780
33. Redrobe J.P., Pinot P., and Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam. Clin. Pharmacol. 10 (1996) 524-528
34. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 21 (2000) 187-193
35. Rodrigues A.L.S., Rocha J.B.T., Mello C.F., and Souza D.O. Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks. Pharmacol. Toxicol. 79 (1996) 150-156
36. Rodrigues A.L.S., Rosa J.M., Gadotti V.M., Goulart E.C., Santos M.M., Silva A.V., Sehnem B., Rosa L.S., Gonçalves R.M., Corrêa R., and Santos A.R.S. Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4″-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice. Pharmacol. Biochem. Behav. 82 (2005) 156-162
37. Santos A.R.S., Gadotti V.M., Oliveira G.L., Tibola D., Paszcuk A.F., Neto A., Spindola H.M., Souza M.M., Rodrigues A.L.S., and Calixto J.B. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 48 (2005) 1021-1034
38. Shieh C.C., Michael C., Sullivan J.P., and Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 52 (2000) 557-594
39. Shin J.H., Chung S., Park E.J., Uhm D.Y., and Suh S.K. Nitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayer. FEBS Lett. 415 (1997) 299-302
40. + channels: molecular determinants and function of the SK family. Nat. Rev., Neurosci. 5 (2004) 758-770
41. Tytgat J., Maertens C., and Daenens P. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br. J. Pharmacol. 122 (1997) 1417-1424
42. + channels as therapeutic drug targets. Pharmacol. Ther. 94 (2002) 157-182
43. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell. Signal. 9 (1997) 1-13
44. + channels in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 9360-9364
45. Yang X.C., and Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 288 (1999) 544-549
46. Yeung S.Y., Millar J.A., and Mathie A. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br. J. Pharmacol. 128 (1999) 1609-1615
47. Zomkowski A.D.E., Hammes L., Lin J., Calixto J.B., Santos A.R.S., and Rodrigues A.L.S. Agmatine produces antidepressant-like effects in two models of depression in mice. NeuroReport 13 (2002) 387-391
48. Zomkowski A.D.E., Rosa A.O., Lin J., Santos A.R.S., Calixto J.B., and Rodrigues A.L.S. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res. 1023 (2004) 253-263
49. Zomkowski A.D.E., Santos A.R.S., and Rodrigues A.L.S. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci. Lett. 381 (2005) 279-283